| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPHEART.00085.2003 |
| P953 | full work available at URL | http://intl-ajpheart.physiology.org/cgi/content/abstract/285/3/H1206 |
| https://www.physiology.org/doi/pdf/10.1152/ajpheart.00085.2003 | ||
| P698 | PubMed publication ID | 12738624 |
| P5875 | ResearchGate publication ID | 7316931 |
| P50 | author | Peter W de Leeuw | Q46001914 |
| P2093 | author name string | Kim van der Zander | |
| Leo Hofstra | |||
| Abraham A. Kroon | |||
| Alphons J. H M. Houben | |||
| P2860 | cites work | Microvascular effects of atrial natriuretic peptide (ANP) in man: studies during high and low salt diet | Q31984377 |
| Diurnal variations in total forearm and skin microcirculatory blood flow in man. | Q36751706 | ||
| Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group | Q48167953 | ||
| Renal effects of brain natriuretic peptide in patients with congestive heart failure | Q48326773 | ||
| Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. | Q48540905 | ||
| Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. | Q48643573 | ||
| Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. | Q53907769 | ||
| Cardiovascular Function during Brain Natriuretic Peptide Infusion in Man | Q54187973 | ||
| Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technic for determination of inulin and para-aminohippurate | Q70504360 | ||
| Acute effects of physiological increments of brain natriuretic peptide in humans | Q71740101 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | physiology | Q521 |
| placebo | Q269829 | ||
| hemodynamics | Q1642137 | ||
| brain natriuretic peptide | Q66360952 | ||
| Cardiology and cardiovascular medicine | Q96320350 | ||
| P304 | page(s) | H1206-12 | |
| P577 | publication date | 2003-05-08 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Hemodynamic and renal effects of low-dose brain natriuretic peptide infusion in humans: a randomized, placebo-controlled crossover study | |
| P478 | volume | 285 |
| Q81117258 | AlbuBNP, a recombinant B-type natriuretic peptide and human serum albumin fusion hormone, as a long-term therapy of congestive heart failure |
| Q48894369 | Association of endostatin with mortality in patients with chronic heart failure. |
| Q42628315 | B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men. |
| Q53615031 | B-type natriuretic peptide increases cortisol and catecholamine concentrations in healthy subjects. |
| Q36249721 | B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men. |
| Q92127154 | BNP as a Major Player in the Heart-Kidney Connection |
| Q36920658 | Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure |
| Q33573360 | Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent |
| Q48852531 | Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. |
| Q57396192 | Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine I |
| Q58318917 | Isolation and Characterization of a Natriuretic Peptide from Crotalus oreganus abyssus (Grand Canyon Rattlesnake) and its Effects on Systemic Blood Pressure and Nitrite Levels |
| Q34891600 | Long-term effects of B-type natriuretic peptide infusion after acute myocardial infarction in a rat model |
| Q42370964 | Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial |
| Q38424318 | Mechanisms of renal hyporesponsiveness to BNP in heart failure. |
| Q89442819 | Natriuretic Peptides and Normal Body Fluid Regulation |
| Q36806952 | Nesiritide for acute decompensated heart failure: does the benefit justify the risk? |
| Q30251531 | Potential new drug treatments for congestive heart failure |
| Q37298343 | Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury |
| Q38871148 | Role of Angiotensin Receptor-Neprilysin Inhibition in Heart Failure |
| Q37537154 | Role of guanylate cyclase modulators in decompensated heart failure |
| Q46976370 | Selective endothelin B receptor blockade does not influence BNP-induced natriuresis in man. |
| Q37826122 | Soluble guanylate cyclase modulators in heart failure |
| Q44136615 | The differential effects of recombinant brain natriuretic peptide, nitroglycerine and dihydralazine on systemic oxygen delivery and gastric mucosal microvascular oxygenation in dogs. |
| Q48702164 | The plasma atrial natriuretic peptide response to arm and leg exercise in humans: effect of posture. |
| Q37523958 | The role of nesiritide in heart failure |
| Q36191278 | Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology |
Search more.